Literature DB >> 24378552

Pathological confirmation of para-aortic lymph node status as a potential criterion for the selection of intrahepatic cholangiocarcinoma patients for radical resection with regional lymph node dissection.

Tomohide Nakayama1, Takahiro Tsuchikawa, Toshiaki Shichinohe, Toru Nakamura, Yuma Ebihara, Satoshi Hirano.   

Abstract

BACKGROUND: Para-aortic lymph node (PAN) metastasis traditionally has been defined as distant metastasis. Many studies suggest that lymph node metastasis in intrahepatic cholangiocarcinoma (ICC) is one of the strongest prognostic factors for patient survival; however, the status of the PAN was not examined separately from regional lymph node metastasis in these reports. Here, we investigated whether regional lymph node metastasis without PAN metastasis in ICC can be classified as resectable disease and whether curative resection can have a prognostic impact.
METHODS: Between 1998 and 2010, a total of 47 ICC patients underwent hepatic resection and systematic lymphadenectomy with curative intent. We routinely dissected the PANs and had frozen-section pathological examinations performed intraoperatively. If PAN metastases were identified, curative resection was abandoned. We retrospectively investigated the prognostic factors for patient survival after curative resection for ICC without PAN metastases, with particular attention paid to the prognostic impact of lymphadenectomy.
RESULTS: Univariate analysis identified concomitant portal vein resection, concomitant hepatic artery resection, intraoperative blood loss, intraoperative transfusion, and residual tumor as significant negative prognostic factors. However, lymph node status was not identified as a significant prognostic factor. The 14 patients with node-positive cancer had a survival rate of 20 % at 5 years. Based on multivariate analysis, intraoperative transfusion was an independent prognostic factor associated with a poor prognosis (risk ratio = 4.161; P = 0.0056).
CONCLUSIONS: Regional lymph node metastasis in ICC should be classified as resectable disease, because the survival rate after surgical intervention was acceptable when PAN metastasis was pathologically negative.

Entities:  

Mesh:

Year:  2014        PMID: 24378552     DOI: 10.1007/s00268-013-2433-7

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  35 in total

1.  Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Authors:  Kazuhisa Uchiyama; Masakazu Yamamoto; Hiroki Yamaue; Shun-ichi Ariizumi; Taku Aoki; Norihiro Kokudo; Tomoki Ebata; Masato Nagino; Masayuki Ohtsuka; Masaru Miyazaki; Eiichi Tanaka; Satoshi Kondo; Takahiro Uenishi; Shoji Kubo; Hiroshi Yoshida; Michiaki Unno; Satoru Imura; Mitsuo Shimada; Masaki Ueno; Tadahiro Takada
Journal:  J Hepatobiliary Pancreat Sci       Date:  2011-05       Impact factor: 7.027

Review 2.  Peripheral cholangiocarcinoma (cholangiocellular carcinoma): clinical features, diagnosis and treatment.

Authors:  M F Chen
Journal:  J Gastroenterol Hepatol       Date:  1999-12       Impact factor: 4.029

3.  The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.

Authors:  Sae-Byeol Choi; Kyung-Sik Kim; Jin-Young Choi; Seung-Woo Park; Jin-Sub Choi; Woo-Jung Lee; Jae-Bock Chung
Journal:  Ann Surg Oncol       Date:  2009-07-22       Impact factor: 5.344

4.  The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma.

Authors:  Y Makino; A Yamanoi; T Kimoto; O N El-Assal; H Kohno; N Nagasue
Journal:  Am J Gastroenterol       Date:  2000-05       Impact factor: 10.864

5.  Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.

Authors:  Ken Shirabe; Yohei Mano; Akinobu Taketomi; Yuji Soejima; Hideaki Uchiyama; Shinichi Aishima; Hiroto Kayashima; Mizuki Ninomiya; Yoshihiko Maehara
Journal:  Ann Surg Oncol       Date:  2010-02-05       Impact factor: 5.344

6.  Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.

Authors:  Alfredo Guglielmi; Andrea Ruzzenente; Tommaso Campagnaro; Silvia Pachera; Alessandro Valdegamberi; Paola Nicoli; Alessandro Cappellani; Giulio Malfermoni; Calogero Iacono
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

7.  Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group.

Authors:  S Pedrazzoli; V DiCarlo; R Dionigi; F Mosca; P Pederzoli; C Pasquali; G Klöppel; K Dhaene; F Michelassi
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

8.  Report of the 15th follow-up survey of primary liver cancer.

Authors:  Iwao Ikai; Yuji Itai; Kiwamu Okita; Masao Omata; Masamichi Kojiro; Kenichi Kobayashi; Yasuni Nakanuma; Shunji Futagawa; Masatoshi Makuuchi; Yoshio Yamaoka
Journal:  Hepatol Res       Date:  2004-01       Impact factor: 4.288

9.  Perineural invasion is a prognostic factor in intrahepatic cholangiocarcinoma.

Authors:  Kazuhisa Shirai; Tomoki Ebata; Koji Oda; Hideki Nishio; Tetsuro Nagasaka; Yuji Nimura; Masato Nagino
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

10.  Patient outcome and prognostic factors in intrahepatic cholangiocarcinoma after hepatectomy.

Authors:  Atsushi Nanashima; Yorihisa Sumida; Takafumi Abo; Toshiya Nagasaki; Hiroaki Takeshita; Hidetoshi Fukuoka; Terumitsu Sawai; Kenji Tanaka; Toru Yasutake; Takeshi Nagayasu
Journal:  Hepatogastroenterology       Date:  2007-12
View more
  3 in total

1.  Prognostic Impact of Tumor Growth Type on 7th AJCC Staging System for Intrahepatic Cholangiocarcinoma: a Single-Center Experience of 659 Cases.

Authors:  Shin Hwang; Young-Joo Lee; Gi-Won Song; Kwang-Min Park; Ki-Hun Kim; Chul-Soo Ahn; Deok-Bog Moon; Sung-Gyu Lee
Journal:  J Gastrointest Surg       Date:  2015-03-28       Impact factor: 3.452

2.  Risk factors for a high Comprehensive Complication Index score after major hepatectomy for biliary cancer: a study of 229 patients at a single institution.

Authors:  Yoshitsugu Nakanishi; Takahiro Tsuchikawa; Keisuke Okamura; Toru Nakamura; Eiji Tamoto; Takehiro Noji; Toshimichi Asano; Toraji Amano; Toshiaki Shichinohe; Satoshi Hirano
Journal:  HPB (Oxford)       Date:  2016-07-19       Impact factor: 3.647

3.  Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels.

Authors:  Zi-Ying Lin; Zhen-Xing Liang; Pei-Lin Zhuang; Jie-Wei Chen; Yun Cao; Li-Xu Yan; Jing-Ping Yun; Dan Xie; Mu-Yan Cai
Journal:  BMC Cancer       Date:  2016-10-12       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.